191 related articles for article (PubMed ID: 7588209)
1. Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts.
King AP; Carter-Su C
Endocrinology; 1995 Nov; 136(11):4796-803. PubMed ID: 7588209
[TBL] [Abstract][Full Text] [Related]
2. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2.
VanderKuur J; Allevato G; Billestrup N; Norstedt G; Carter-Su C
J Biol Chem; 1995 Mar; 270(13):7587-93. PubMed ID: 7535773
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling.
Yarwood SJ; Sale EM; Sale GJ; Houslay MD; Kilgour E; Anderson NG
J Biol Chem; 1999 Mar; 274(13):8662-8. PubMed ID: 10085104
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone.
von Laue S; Finidori J; Maamra M; Shen XY; Justice S; Dobson PR; Ross RJ
J Endocrinol; 2000 May; 165(2):301-11. PubMed ID: 10810294
[TBL] [Abstract][Full Text] [Related]
6. Distinct cytoplasmic domains of the growth hormone receptor are required for glucocorticoid- and phorbol ester-induced decreases in growth hormone (GH) binding. These domains are different from that reported for GH-induced receptor internalization.
King AP; Tseng MJ; Logsdon CD; Billestrup N; Carter-Su C
J Biol Chem; 1996 Jul; 271(30):18088-94. PubMed ID: 8663346
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor and lysophosphatidic acid inhibit growth hormone binding and signaling via a protein kinase C-dependent pathway.
Rui L; Archer SF; Argetsinger LS; Carter-Su C
J Biol Chem; 2000 Jan; 275(4):2885-92. PubMed ID: 10644756
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.
Stofega MR; Argetsinger LS; Wang H; Ullrich A; Carter-Su C
J Biol Chem; 2000 Sep; 275(36):28222-9. PubMed ID: 10842184
[TBL] [Abstract][Full Text] [Related]
13. Evidence for involvement of the growth hormone receptor-associated tyrosine kinase in actions of growth hormone.
Campbell GS; Christian LJ; Carter-Su C
J Biol Chem; 1993 Apr; 268(10):7427-34. PubMed ID: 8385106
[TBL] [Abstract][Full Text] [Related]
14. Termination of growth hormone pulse-induced STAT5b signaling.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1999 Jan; 13(1):38-56. PubMed ID: 9892011
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1.
Argetsinger LS; Hsu GW; Myers MG; Billestrup N; White MF; Carter-Su C
J Biol Chem; 1995 Jun; 270(24):14685-92. PubMed ID: 7782332
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts.
Kim SO; Houtman JC; Jiang J; Ruppert JM; Bertics PJ; Frank SJ
J Biol Chem; 1999 Dec; 274(50):36015-24. PubMed ID: 10585492
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
[TBL] [Abstract][Full Text] [Related]
18. Signalling pathway of GH.
Carter-Su C; King AP; Argetsinger LS; Smit LS; Vanderkuur J; Campbell GS
Endocr J; 1996 Oct; 43 Suppl():S65-70. PubMed ID: 9076344
[TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling.
Gu F; Dubé N; Kim JW; Cheng A; Ibarra-Sanchez Mde J; Tremblay ML; Boisclair YR
Mol Cell Biol; 2003 Jun; 23(11):3753-62. PubMed ID: 12748279
[TBL] [Abstract][Full Text] [Related]
20. A role for Grb2-associated binder-1 in growth hormone signaling.
Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
